DXPE News Alert Dxp Enterprises (DXPE) 46.57 02/13/2015 23:2

New Post Public Reply Private Reply Replies (0) Message Board

Feb 14, 2015 at 12:21 AM

Dxp Enterprises (DXPE) 46.57 $DXPE

Downtrend Call Working As DXP Enterprises Stock Falls 42.1% (DXPE)
Comtex SmarTrend(R) - Mon Feb 09, 9:37AM CST
SmarTrend identified a Downtrend for DXP Enterprises (NASDAQ

XPE) on May 13th, 2014 at $77.20. In approximately 9 months, DXP Enterprises has returned 42.06% as of today's recent price of $44.73.
DXPE: 46.57 (+1.42)

46.7% Return Seen to Date on SmarTrend DXP Enterprises Call (DXPE)
Comtex SmarTrend(R) - Mon Feb 02, 9:14AM CST
SmarTrend identified a Downtrend for DXP Enterprises (NASDAQ

XPE) on May 13th, 2014 at $77.20. In approximately 9 months, DXP Enterprises has returned 46.67% as of today's recent price of $41.17.
DXPE: 46.57 (+1.42)

What Falling Estimates & Price Mean for DXP Enterprises (DXPE) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 20, 7:51AM CST
DXP Enterprises is one such stock that can be considered to drop as it has witnessed a significant price decline and has seen negative earnings estimate revisions
KAI: 41.89 (-0.03), DXPE: 46.57 (+1.42)

Shares of DXPE Down 48.0% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Jan 16, 11:02AM CST
SmarTrend identified a Downtrend for DXP Enterprises (NASDAQ

XPE) on May 13th, 2014 at $77.20. In approximately 8 months, DXP Enterprises has returned 47.96% as of today's recent price of $40.17.
DXPE: 46.57 (+1.42)

Commit To Buy DXP Enterprises At $35, Earn 14.8% Annualized Using Options
at The Street - Wed Jan 14, 10:39AM CST
Investors considering a purchase of DXP Enterprises, Inc. stock, but tentative about paying the going market price of $41.07/share, might benefit from considering selling puts among the alternative strategies at their disposal.
DXPE: 46.57 (+1.42)

Nasdaq stocks posting largest percentage decreases
AP - Tue Jan 13, 5:15PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
DISCK: 30.32 (+0.80), ARWR: 6.77 (+0.21), AFMD: 5.70 (-0.25), TFM: 37.14 (+0.07), SRPT: 12.76 (+0.11), DISCB: 31.64 (+0.64), DISCA: 31.45 (+1.11), POZN: 6.95 (+0.15), PEIX: 9.82 (+0.15), GFN: 9.20 (+0.25), HLSS: 16.15 (-0.14), DXPE: 46.57 (+1.42), OBAS: 6.25 (-0.05)

Machinery Stock Outlook - Jan. 2015 - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Jan 13, 12:00AM CST
Machinery Stock Outlook - Jan. 2015 - Industry Outlook
NDSN: 78.04 (+1.37), LNN: 88.94 (-0.02), AGCO: 49.78 (+0.97), EMR: 58.68 (+0.08), CFX: 52.02 (+3.84), ESE: 37.16 (+0.22), LECO: 72.23 (+1.06), ASTE: 38.49 (+0.06), ROLL: 61.78 (-0.39), MTW: 21.86 (+0.34), ITW: 98.26 (+0.48), AOS: 62.76 (+0.10), DXPE: 46.57 (+1.42), SWK: 98.20 (+0.92), IEX: 77.14 (+0.77), KMT: 35.44 (+0.86), ATU: 25.51 (+0.35), DE: 90.04 (+0.67), MIDD: 105.62 (+1.51), DOV: 74.41 (+1.13), TEX: 25.15 (+0.19), CAT: 85.13 (+1.60), ALG: 49.00 (+0.93)

Machinery Stock Outlook - Jan. 2015 - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Jan 13, 12:00AM CST
Machinery Stock Outlook - Jan. 2015 - Zacks Analyst Interviews
NDSN: 78.04 (+1.37), LNN: 88.94 (-0.02), AGCO: 49.78 (+0.97), EMR: 58.68 (+0.08), CFX: 52.02 (+3.84), ESE: 37.16 (+0.22), LECO: 72.23 (+1.06), ASTE: 38.49 (+0.06), ROLL: 61.78 (-0.39), MTW: 21.86 (+0.34), ITW: 98.26 (+0.48), AOS: 62.76 (+0.10), DXPE: 46.57 (+1.42), SWK: 98.20 (+0.92), IEX: 77.14 (+0.77), KMT: 35.44 (+0.86), ATU: 25.51 (+0.35), DE: 90.04 (+0.67), MIDD: 105.62 (+1.51), DOV: 74.41 (+1.13), TEX: 25.15 (+0.19), CAT: 85.13 (+1.60), ALG: 49.00 (+0.93)

DXP Enterprises Down 36.0% Since SmarTrend Downtrend Call (DXPE)
Comtex SmarTrend(R) - Fri Jan 09, 9:46AM CST
SmarTrend identified a Downtrend for DXP Enterprises (NASDAQ

XPE) on May 13th, 2014 at $77.20. In approximately 8 months, DXP Enterprises has returned 35.97% as of today's recent price of $49.43.
DXPE: 46.57 (+1.42)

Graco (GGG) on Acquisition Spree to Fuel Growth Momentum - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 05, 9:30AM CST
Graco Inc. (GGG) recently went on an acquisition spree when it bought four separate companies for an aggregate sum of $185 million.
GGG: 75.19 (+0.81), IR: 67.69 (+0.06), ITW: 98.26 (+0.48), DXPE: 46.57 (+1.42)

3M (MMM) Completes Divesture of Static Control Business - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 05, 9:00AM CST
3M Company (MMM) recently completed the divesture of its Static Control business to Desco Industries, Inc. for an undisclosed amount.
MMM: 165.94 (+0.03), IR: 67.69 (+0.06), ITW: 98.26 (+0.48), DXPE: 46.57 (+1.42)

34.1% Return Seen to Date on SmarTrend DXP Enterprises Call (DXPE)
Comtex SmarTrend(R) - Fri Jan 02, 9:14AM CST
SmarTrend identified a Downtrend for DXP Enterprises (NASDAQ

XPE) on May 13th, 2014 at $77.20. In approximately 8 months, DXP Enterprises has returned 34.06% as of today's recent price of $50.90.
DXPE: 46.57 (+1.42)

DXP Enterprises Has Returned 33.2% Since SmarTrend Recommendation (DXPE)
Comtex SmarTrend(R) - Wed Dec 24, 4:53PM CST
SmarTrend identified a Downtrend for DXP Enterprises (NASDAQ

XPE) on May 13th, 2014 at $77.20. In approximately 8 months, DXP Enterprises has returned 33.22% as of today's recent price of $51.55.
DXPE: 46.57 (+1.42)

Ingersoll Hits 52-Week High on Inorganic Growth Strategy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 8:50AM CST
Ingersoll-Rand Plc (IR) scaled a new 52-week high of $64.94 on Dec 23, 2014.
IR: 67.69 (+0.06), ITW: 98.26 (+0.48), NPO: 63.37 (+0.28), DXPE: 46.57 (+1.42)

DXP Enterprises to Buy Back 0.4 Million Shares, Price Rises - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 18, 10:20AM CST
DXP Enterprises, Inc. (DXPE) recently announced a new share buyback program, involving roughly 0.4 million common shares. The program is valid till Dec 2016.
MIDD: 105.62 (+1.51), SNHY: 38.48 (+0.17), BLT: 16.10 (+0.36), DXPE: 46.57 (+1.42)

DXP Enterprises Down 41.7% Since SmarTrend Downtrend Call (DXPE)
Comtex SmarTrend(R) - Wed Dec 17, 11:01AM CST
SmarTrend identified a Downtrend for DXP Enterprises (NASDAQ

XPE) on May 13th, 2014 at $77.20. In approximately 7 months, DXP Enterprises has returned 41.67% as of today's recent price of $45.03.
DXPE: 46.57 (+1.42)

DXP Enterprises Announces Stock Repurchase Program
Business Wire - Wed Dec 17, 10:45AM CST
DXP Enterprises, Inc. (NASDAQ: DXPE) today announces DXP's Board of Directors authorized the repurchase of up to 400,000 shares of DXP's common stock. Under the authorization, the Company from time to time, over the next 24 months, would repurchase shares in the open market or through privately negotiated transactions depending on market conditions and other relevant factors. The primary purpose of the share repurchase plan is to offset potential dilution from shares issued under DXP's Restricted Stock Plan. The repurchase plan which was authorized in May, 2014 has been completed.
DXPE: 46.57 (+1.42)

DXP Enterprises (DXPE) Downgraded From Buy to Hold
at The Street - Tue Dec 16, 9:20AM CST
DXP Enterprises (DXPE) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+.
DXPE: 46.57 (+1.42)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2GenPen & LordCap Team Up: Game-Changer in ABS?

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Florida Cancer Center Expands Expertise with New Oncologist

Welcoming a Highly Skilled Oncologist to Fort Myers There's an old saying in the world of investing: follow the expertise. And when it comes to healthcare, especially cancer treatment, expertise can make a world of difference. Florida Cancer Specialists & Research Institute (FCS) is throwing its hat in the ring with authority, as they welcome Dr. Kelly Elleson, a surgical...

Costa Rican Firms Chase Growth at SIAL Paris 2026

Chasing Growth in Paris: Costa Rica's Bold Move When it comes to playing the global field, Costa Rica isn't just sitting back; they're on the move. Picture this: PROCOMER, along with 18 standout companies, landed smack dab in the grand hustle and bustle of SIAL Paris 2026. This isn't some leisurely stroll—it's a calculated sprint toward expanding their reach across...

Alpha Rising Joins RFP: A Strong AI-Fueled Expansion

The Shift: From LPL to AI-Driven Innovation Hold onto your hats, because Alpha Rising Wealth Management has taken a significant leap from the traditional ship of LPL Financial to the cutting-edge shores of Rothschild Financial Partners (RFP). It's a move that's painting the walls in Scottsdale, Arizona with $250 million in client assets, all set to benefit from a modern,...

Tenet® Beef: Revolutionizing Tenderness in America's Steaks

Cracking the Code: A Genetic Leap in Beef Tenderness Well, buckle up, folks, because Callipyge Genetics is shaking things up in the beef aisle with their genomic breakthrough, Tenet®. It's about time we see some real innovation in an industry that's, let's face it, been slow to evolve. This isn't just a flash in the pan—a bit of DNA parsing has uncovered how to...

Navigating the Nitty-Gritty of Cabin Rental Management

The Real Elbow Grease Behind Cabin Management Ever imagined what it’d take to keep a vacation rental cabin running like a tight ship? Well, Nathan Fitts breaks it down real clear-like. The guy's seen it all in Blue Ridge, Georgia, which isn't just about scenic views—there's serious business brewing behind that cabin charm. More Than Just Fluffing Pillows Turns out,...

Cancer Memoir Shows Healing Beyond Medicine

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Firmable's Tech Intelligence: New Edge in B2B Sales

New Era for B2B Sales Teams Once again, the B2B sales landscape is getting a jolt—especially for those who’ve been fumbling in the dark pitching to prospects without any real idea of their tech environment. With the introduction of Firmable's Tech Intelligence, those blind days just got a lot brighter. By offering detailed insights into what technologies a company is...

Endava Faces Securities Fraud Lawsuit: Investor Implications

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...

DOCS Faces Investor Legal Battle for Alleged Misconduct

The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...